Next Article in Journal
Novel GMO-Based Vaccines against Tuberculosis: State of the Art and Biosafety Considerations
Next Article in Special Issue
Peptide Vaccine: Progress and Challenges
Previous Article in Journal
Identifying the Conditions Under Which Antibodies Protect Against Infection by Equine Infectious Anemia Virus
Previous Article in Special Issue
Pleurocidin Peptide Enhances Grouper Anti-Vibrio harveyi Immunity Elicited by Poly(lactide-co-glycolide)-Encapsulated Recombinant Glyceraldehyde-3-phosphate Dehydrogenase
 
 
Review

Article Versions Notes

Vaccines 2014, 2(2), 422-462; https://doi.org/10.3390/vaccines2020422
Action Date Notes Link
article pdf uploaded. 13 June 2014 14:44 CEST Version of Record https://www.mdpi.com/2076-393X/2/2/422/pdf
article xml file uploaded 14 January 2015 05:17 CET Original file https://www.mdpi.com/2076-393X/2/2/422/xml
article html file updated 14 January 2015 05:17 CET Original file -
article html file updated 20 August 2015 09:53 CEST Update -
article html file updated 21 March 2019 18:48 CET Update -
article html file updated 7 May 2019 13:09 CEST Update -
article html file updated 20 September 2019 09:15 CEST Update -
article html file updated 6 February 2020 09:56 CET Update -
article html file updated 15 July 2022 23:07 CEST Update https://www.mdpi.com/2076-393X/2/2/422/html
Back to TopTop